Pengpeng Liang

机构：Shanghai University of Traditional Chinese Medicine, Shenzhen Luohu People's Hospital · ORCID：0000-0003-2342-2719

发表论文 13 篇 · 总被引 211 次 · h-index 8

代表论文

• The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review (2021 · Diabetes Metabolic Syndrome and Obesity · 被引 47)
• Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway (2023 · European Journal of Pharmacology · 被引 41)
• Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver (2022 · Drug Design Development and Therapy · 被引 37)
• The association between novel metabolic parameters and all-cause/cardiovascular mortality in patients with metabolic syndrome is modified by age (2025 · Cardiovascular Diabetology · 被引 20)
• Studies of the anti-AIDS effects of marine polysaccharide drug 911 and its related mechanisms of action (2000 · 被引 16)
• Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo (2022 · Frontiers in Pharmacology · 被引 15)